CDC Recommends: If the CAUTI rate is not decreasing after implementing a comprehensive strategy to reduce rates of CAUTI, consider using antimicrobial/
antiseptic-impregnated catheters. (Category 1B)

Only BARDEX® I.C. Infection Control Foley Catheter Systems are clinically proven to reduce catheter-associated urinary tract infections (CAUTIs) (Category 2B).

A technologically advanced formulation consisting of Bacti-Guard®* silver alloy and hydrogel coating on a urinary catheter reduces bacterial adherence.

This unique formulation strikes a precise balance between reduction of bacterial adhesion and minimization of urethral damage thereby reducing the patient’s risk of infection.

The Occurrence of UTI is 3.7 times greater in patients catheterized with a standard catheter than in patients catheterized with the Bardex® I.C. Foley Catheter with Bacti-Guard® silver alloy coating and Bard® Hydrogel.  (95 C.I., 2.0-6.8).

This site is intended for healthcare professionals. If you are a patient seeking more information regarding Catheter Associated Urinary Tract Infection (CAUTI) prevention, please consult your healthcare provider.